Principal component analysis of synaptic density measured with [11C]UCB-J PET in early Alzheimer’s disease

Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J

(2021) Ryan S. O’Dell et al.   Alzheimers Research & Therapy

In vivo tau pathology is associated with synaptic loss and altered synaptic function

(2021) Emma M. Coomans et al.   Alzheimers Research & Therapy

Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study

(2021) Ming-Kai Chen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ 11 C ] UCB‐J PET Imaging Study

(2021) Katrine B. Andersen et al.   MOVEMENT DISORDERS

Synaptic density in carriers of C9orf72 mutations: a [ 11 C]UCB‐J PET study

(2021) Maura Malpetti et al.   Annals of Clinical and Translational Neurology

Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease

(2021) Aline Delva et al.   NEUROLOGY

Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease

(2021) Adam P. Mecca et al.   NEUROBIOLOGY OF AGING

Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET

(2020) Renaud La Joie et al.   Science Translational Medicine

PET imaging of mGluR5 in Alzheimer’s disease

(2020) Adam P. Mecca et al.   Alzheimers Research & Therapy

In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET

(2020) Adam P. Mecca et al.   Alzheimers & Dementia

Synaptic Loss in Primary Tauopathies Revealed by [ 11 C ] UCB‐J Positron Emission Tomography

(2020) Negin Holland et al.   MOVEMENT DISORDERS

Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease

(2020) Aline Delva et al.   MOVEMENT DISORDERS

In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment

(2020) Heleen Vanhaute et al.   NEUROLOGY

Neurodegenerative changes in early- and late-onset cognitive impairment with and without brain amyloidosis

(2020) Eddie C. Stage et al.   Alzheimers Research & Therapy

Principal components analysis based measures of PET data closely reflect neuropathological staging schemes

(2020) Ganna Blazhenets et al.   JOURNAL OF NUCLEAR MEDICINE

Validation of Parametric Methods for [11C]UCB-J PET Imaging Using Subcortical White Matter as Reference Tissue

(2019) Nathalie Mertens et al.   MOLECULAR IMAGING AND BIOLOGY

In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography

(2019) Christine Bastin et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Assessment of a white matter reference region for 11C-UCB-J PET quantification

(2019) Samantha Rossano et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Predictive Value of 18F-Florbetapir and 18F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia

(2019) Ganna Blazhenets et al.   JOURNAL OF NUCLEAR MEDICINE

Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease

(2018) Adam P. Mecca et al.   NEUROBIOLOGY OF AGING

Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging

(2018) Ming-Kai Chen et al.   JAMA Neurology

Principal component analysis of brain metabolism predicts development of Alzheimer’s dementia

(2018) Ganna Blazhenets et al.   JOURNAL OF NUCLEAR MEDICINE

Kinetic evaluation and test–retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans

(2017) Sjoerd J Finnema et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability

(2016) Martijn C. de Wilde et al.   Alzheimers & Dementia

APOE -Sensitive Cholinergic Sprouting Compensates for Hippocampal Dysfunctions Due to Reduced Entorhinal Input

(2016) Jean-Bastien Bott et al.   JOURNAL OF NEUROSCIENCE

Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain

(2016) N. B. Nabulsi et al.   JOURNAL OF NUCLEAR MEDICINE

Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases

(2016) Paul J. Mattis et al.   NEUROLOGY

Imaging synaptic density in the living human brain

(2016) Sjoerd J. Finnema et al.   Science Translational Medicine

Is synaptic loss a unique hallmark of Alzheimer's disease?

(2014) Stephen W. Scheff et al.   BIOCHEMICAL PHARMACOLOGY

A disease-specific metabolic brain network associated with corticobasal degeneration

(2014) Martin Niethammer et al.   BRAIN

The Alzheimer’s Disease-Related Glucose Metabolic Brain Pattern

(2014) Laura Teune et al.   Current Alzheimer Research

Evaluation of motion correction methods in human brain PET imaging-A simulation study based on human motion data

(2013) Xiao Jin et al.   MEDICAL PHYSICS

FreeSurfer

(2012) Bruce Fischl   NEUROIMAGE

A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology

(2012) Kjell Erlandsson et al.   PHYSICS IN MEDICINE AND BIOLOGY

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer’s disease brain

(2011) J S Rao et al.   Translational Psychiatry

Fibrillar amyloid-  burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

(2009) E. M. Reiman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

(2008) Bradford C. Dickerson et al.   CEREBRAL CORTEX

Principal component analysis of FDG PET in amnestic MCI

(2008) Flavio Nobili et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Abnormal metabolic networks in atypical parkinsonism

(2008) Thomas Eckert et al.   MOVEMENT DISORDERS

Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease

(2008) Christian Habeck et al.   NEUROIMAGE

On the multivariate nature of brain metabolic impairment in Alzheimer's disease

(2007) Eric Salmon et al.   NEUROBIOLOGY OF AGING